BR9202830A - Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao - Google Patents

Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao

Info

Publication number
BR9202830A
BR9202830A BR929202830A BR9202830A BR9202830A BR 9202830 A BR9202830 A BR 9202830A BR 929202830 A BR929202830 A BR 929202830A BR 9202830 A BR9202830 A BR 9202830A BR 9202830 A BR9202830 A BR 9202830A
Authority
BR
Brazil
Prior art keywords
atoms
phenyl
alkyl
hypertension
prevention
Prior art date
Application number
BR929202830A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Paul Clozel
Rita Mueller
Wolfgang Osterrieder
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9202830A publication Critical patent/BR9202830A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
BR929202830A 1991-07-23 1992-07-23 Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao BR9202830A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219191 1991-07-23

Publications (1)

Publication Number Publication Date
BR9202830A true BR9202830A (pt) 1993-03-23

Family

ID=4228024

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929202830A BR9202830A (pt) 1991-07-23 1992-07-23 Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao

Country Status (31)

Country Link
US (1) US5620975A (da)
EP (1) EP0524512B1 (da)
JP (1) JPH0680009B2 (da)
KR (1) KR100260479B1 (da)
CN (1) CN1040505C (da)
AT (1) ATE260661T1 (da)
AU (1) AU656207B2 (da)
BG (1) BG60949B1 (da)
BR (1) BR9202830A (da)
CA (1) CA2074039C (da)
CZ (1) CZ281691B6 (da)
DE (1) DE59209993D1 (da)
DK (1) DK0524512T3 (da)
ES (1) ES2215160T3 (da)
HR (1) HRP930953B1 (da)
HU (1) HU214029B (da)
IE (1) IE922378A1 (da)
IL (1) IL102541A (da)
IS (1) IS3887A (da)
MX (1) MX9204212A (da)
MY (1) MY118064A (da)
NO (1) NO301047B1 (da)
NZ (1) NZ243577A (da)
PT (1) PT524512E (da)
RO (1) RO110905B (da)
RU (1) RU2084225C1 (da)
SK (1) SK278918B6 (da)
TW (1) TW216770B (da)
UY (1) UY23449A1 (da)
YU (2) YU49198B (da)
ZA (1) ZA925322B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT634175E (pt) * 1993-07-15 2001-06-29 Hoffmann La Roche Combinacao farmaceutica que contem um inibidor do sistema renina-angiotensina e o antagonista de endotelina
IL131816A (en) 1997-04-04 2003-06-24 Exxon Res & Engineering Compan Composite structures having high containment strength
US6608097B2 (en) 2001-10-10 2003-08-19 Aryx Therapeutics Materials and methods for the treatment of hypertension and angina
US7687086B1 (en) 2003-02-28 2010-03-30 University Of Portland Method for obtaining taxanes
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
DK171349B1 (da) * 1986-11-14 1996-09-16 Hoffmann La Roche Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
KR940005408B1 (ko) * 1990-12-03 1994-06-18 만도기계 주식회사 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치

Also Published As

Publication number Publication date
CZ281691B6 (cs) 1996-12-11
NO922903D0 (no) 1992-07-22
AU2041692A (en) 1993-01-28
SK227092A3 (en) 1996-02-07
CA2074039A1 (en) 1993-01-24
HU214029B (en) 1997-12-29
YU49198B (sh) 2004-09-03
TW216770B (da) 1993-12-01
BG60949B1 (bg) 1996-07-31
ES2215160T3 (es) 2004-10-01
RO110905B (ro) 1996-05-30
DE59209993D1 (de) 2004-04-08
AU656207B2 (en) 1995-01-27
DK0524512T3 (da) 2004-07-05
CN1068737A (zh) 1993-02-10
HUT62792A (en) 1993-06-28
BG96664A (bg) 1993-12-24
HRP930953B1 (en) 2003-06-30
CZ227092A3 (en) 1993-02-17
KR930001910A (ko) 1993-02-22
EP0524512A3 (en) 1993-09-01
IL102541A0 (en) 1993-01-14
IL102541A (en) 1995-12-08
NO301047B1 (no) 1997-09-08
HRP930953A2 (en) 1995-10-31
IE922378A1 (en) 1993-01-27
RU2084225C1 (ru) 1997-07-20
UY23449A1 (es) 1993-01-21
MY118064A (en) 2004-08-30
IS3887A (is) 1993-01-24
NZ243577A (en) 1994-09-27
YU72392A (sh) 1997-05-28
PT524512E (pt) 2004-07-30
US5620975A (en) 1997-04-15
EP0524512A2 (de) 1993-01-27
JPH0680009B2 (ja) 1994-10-12
NO922903L (no) 1993-01-25
ATE260661T1 (de) 2004-03-15
SK278918B6 (sk) 1998-04-08
HU9202367D0 (en) 1992-10-28
MX9204212A (es) 1993-08-01
CA2074039C (en) 2004-11-02
JPH05194217A (ja) 1993-08-03
EP0524512B1 (de) 2004-03-03
KR100260479B1 (ko) 2000-07-01
CN1040505C (zh) 1998-11-04
ZA925322B (en) 1993-03-31

Similar Documents

Publication Publication Date Title
FI875202A (fi) Steroider med en spiranring i 17-staellning, foerfarande foer framstaellning av dessa och anvaendning av dessa.
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2081120T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y la desacetil-10 bacatina iii.
KR930703319A (ko) 키산틴 유도체
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
PT695183E (pt) Utilizacao de tiazolidinodionas para o tratamento da aterosclerose e perturbacoes alimentares
ATE126221T1 (de) Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
BR9202830A (pt) Preparacao de combinacao farmaceutica,processo para sua fabricacao,uso e processo de tratamento ou prevencao de hipertensao
TW230771B (da)
MX9633A (es) Procedimiento para la preparacion de nuevos productos esteroides que llevan en la posicion 23 un radical sulfinilo y producto obtenido.
ATE56442T1 (de) 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES531318A0 (es) Procedimiento para la obtencion de derivados quinolinicos
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
AU3626189A (en) New derivatives of phenothiazine, their preparation and the compositions which contain them
BR0012592A (pt) Composto, uso dos compostos, combinação, e, preparação farmacêutica para uso oral ou parenteral
DE59104443D1 (de) Sulfonamide enthaltende arzneimittel, neue sulfonamide und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFA Appeal against deemed withdrawal